Mi Meng Hua

Buddleja officinalis Maxim.

Also known as: Pale Butterflybush Flower(English) 密蒙花(Chinese)

Milmonghwa密蒙花 밀몽화 Mật mông hoa

Updated October 5, 2026 · Not yet clinically reviewed

Mi Meng Hua
Curtis's Botanical Magazine, 1911 · public domain, via Wikimedia Commons

Safety at a glance

Caution

3 recorded drug interactions, 1 major or contraindicated

Note

Contraindications or side effects are listed

No rule in our tables for this herb: pregnancy, breastfeeding, incompatible pairs (十八反 / 十九畏), herb–drug, dose ceiling. This is not a safety clearance.
Not graded —

No toxicity grade is recorded. Most herbs in the catalogue carry none.

Traditional Chinese Medicine

Category
clearing heat
Temperature
Cool
Taste
Sweet
Channels
Liver

Functions

Clears Liver Heat; Brightens the Eyes; Brightens the Eyes and Removes Visual Obstructions; Tonifies the Liver; Disperses Wind; Cools the Blood

Traditional uses

Mi Meng Hua (buddleia flower bud) is a cool herb used exclusively in Chinese medicine for eye conditions. It clears Liver Heat and brightens the eyes, addressing red, swollen, painful eyes from Liver Heat or Wind-Heat, excessive tearing, light sensitivity, blurred vision, and corneal cloudiness. Unique among eye herbs, it can be applied for both excess Heat-type eye conditions and deficiency-type visual decline — making it one of the most versatile ophthalmologic herbs in the TCM materia medica.

Western herbalism

Properties: anti-inflammatory

Formulas using this herb

3 of 3 formulas

Botanical

Buddleja officinalis, the pale butterfly bush or Mi Meng Hua, is a semi-evergreen shrub in the Scrophulariaceae (formerly Loganiaceae or Buddlejaceae) family, native to central and southwestern China. It grows to 1-4 m with quadrangular young branches densely covered in stellate gray-white tomentum. Leaves are opposite, lanceolate to elliptic, 5-20 cm long, with grayish hairy undersides. Fragrant pale lilac to violet tubular flowers with orange throats are borne in dense terminal panicles in late winter and early spring. Unopened flower buds are harvested in early spring before opening, then sun-dried for medicinal use.

Family
Loganiaceae
Pharmaceutical name
Flos Buddlejae
Parts used
flower
Plant type
shrub

Constituents

Linarin (acacetin 7-O-rutinoside)

Flavone glycoside · the Chinese Pharmacopoeia 2020 assay requires not less than 0.50% linarin in the dried flower bud

The single official quality marker for this drug, and the compound the Pharmacopoeia identity of Mi Meng Hua is built on. Isolated linarin suppressed nitric oxide, TNF-alpha and IL-1beta production in stimulated cells, which is the mechanistic basis usually offered for the traditional heat-clearing action.

Acteoside (verbascoside)

Phenylethanoid glycoside

HPLC-DAD profiling of B. officinalis flowers found acteoside present in the greatest amount of any single constituent, more abundant than the official marker linarin, and the authors argued it should be added as a second quality index. It shares linarin's inhibition of nitric oxide, TNF-alpha and IL-1beta.

Acacetin

Flavone aglycone

The aglycone of linarin and, with luteolin and apigenin, one of the three flavone monomers of the total Buddleja officinalis flavonoid fraction. That fraction reduced hydrogen-peroxide-induced injury in cultured lens cells by modulating oxidative stress and autophagy, the strand of work behind the herb's eye indications.

Luteolin

Flavone

Present both free and as luteolin 7-O-glucoside and luteolin 7-O-rutinoside. One of the three main monomers of the flavonoid fraction studied in lens cell oxidative injury.

Apigenin

Flavone

Occurs free and as cosmosiin (apigenin 7-O-glucoside), apigenin 7-O-glucuronide and isorhoifolin. Contributes to the antioxidant activity of the total flavonoid fraction.

Echinacoside

Phenylethanoid glycoside

A second major phenylethanoid of the flower bud alongside acteoside. It is a widely distributed compound and is not diagnostic for this species.

Mimengoside A and mimengoside B

Triterpenoid (saponin) glycoside

Saponins characterised from the flower buds of B. officinalis. Their presence means the crude drug carries a saponin load, which is the usual explanation for gastric irritation with large decoction doses; no specific toxicity data for these compounds in humans has been published.

Crocin I, crocin II and crocin III

Carotenoid (crocetin) glycoside

The water-soluble yellow pigments of the flower bud, the same class of compound that colours saffron. They are why Mi Meng Hua has a parallel history as a yellow food and textile dye, and they are useful chromatographic markers for the genuine drug.

Methylcatalpol and 6-O-vanilloyl ajugol

Iridoid glycoside

Iridoids detected in the comprehensive HPLC-Q-TOF-MS/MS profile of the flowers. They are minor components and are not used for quality control.

Drug interactions

Daphne genkwa (Yuan Hua) supplied as Mi Meng Hua

Major · Substitution of a toxic drastic purgative for a mild heat-clearing eye herb, with risk of violent diarrhoea, dehydration and mucosal irritation · Evidence level: Probable

Chinese herbological review work on the origins of Mi Meng Hua records that, through regional habit, Thymelaeaceae flower buds including Edgeworthia chrysantha and Daphne genkwa, and even Syringa oblata buds, have all been sold as the source of this drug, muddling its botanical origin. Daphne genkwa is a different drug entirely: a toxic, drastically purgative flower bud that contains daphnane diterpene orthoesters, is dose-restricted, and is one of the classical eighteen incompatibilities with Gan Cao (licorice). A patient given it in place of Buddleja gets a cathartic instead of an eye herb.

Clinical note: Buy Mi Meng Hua only against a Pharmacopoeia linarin assay and reject material that is not the grey-brown to yellow-brown, densely star-hairy panicle of small buds. Never accept flower buds in tight silky-haired heads.

Edgeworthia chrysantha flower bud (Jie Xiang Hua, sold as Xin Meng Hua or Ye Meng Hua)

Moderate · Therapeutic failure: the patient receives an unrelated Thymelaeaceae drug with none of the flavonoid activity Mi Meng Hua is prescribed for · Evidence level: Established

Edgeworthia chrysantha buds are a documented adulterant of Mi Meng Hua and have been used in its place in Guizhou and Fujian; the Hong Kong Chinese Medicine regulatory authority publishes a formal differentiation study of the two. Edgeworthia is not in the Chinese Pharmacopoeia and does not contain the acacetin and linarin flavonoids to which the capillary and ocular effects of Mi Meng Hua are attributed. Macroscopically the genuine drug is a panicle of buds under grey-white to yellow-brown stellate hairs, while the adulterant is a compact head with pale silky hairs on stout three-forked twigs.

Clinical note: Inspect for the branched panicle and stellate (not silky) indumentum, and require the linarin assay. Do not accept material invoiced as Xin Meng Hua or Ye Meng Hua.

Topical ophthalmic preparations and eye drops

Theoretical · Unknown; no sterility or ocular tolerance data exist for practitioner-prepared Buddleja washes · Evidence level: Theoretical

The modern evidence for this herb in dry eye is a rabbit and rat model of castration-induced dry eye treated with a manufactured, standardised B. officinalis eye drop, not a decoction. Extrapolating that to a home-made herbal eye wash is unwarranted: the animal work says nothing about sterility, tonicity, pH or preservative safety on the ocular surface, and none of these has been characterised for the crude drug.

Clinical note: Use Mi Meng Hua orally. Do not compound decoctions or infusions of it into eye drops or eye washes, and do not present the animal dry-eye data as support for topical ocular use in humans.

Dosage

FormAmountFrequencyNotes
decoction3–9 gDaily
中国药典 2020 【用法与用量】3~9g。 【性味与归经】甘,微寒。归肝经。 — Chinese Pharmacopoeia 2020, quoted verbatim; route and cautions preserved. Replaces a cleared category-filler value.

Evidence

Study design on record, not certainty of outcome.

In vitro / animal
3

The Effect of Buddleja officinalis Maxim Eye Drops on Morphology and Apoptosis in Lacrimal Gland of Experimental Dry Eye Rabbit Model

Qin G, Zhou Y, Peng J, Zhang Y, Peng X, Peng Q, Yang Y · Journal of Ophthalmology · 2019 · animal

In vitro / animal · Not yet verified

Thirty-six male rabbits were made dry-eyed by bilateral testiculectomy and epididymectomy, then treated with B. officinalis eye drops at several concentrations, with testosterone and untreated model animals as comparators. The Buddleja drops improved lacrimal gland morphology and reduced acinar cell apoptosis relative to untreated model animals. This is an androgen-deficiency dry eye model in rabbits, not a human trial, and it used a manufactured eye drop rather than the crude drug.

doi:10.1155/2019/5916243

Extraction and Purification of Flavonoids from Buddleja officinalis Maxim and Their Attenuation of H2O2-Induced Cell Injury by Modulating Oxidative Stress and Autophagy

Wei S, Liu X, Hasan KMF, Peng Y, Xie J, Chen S, Zeng Q, Luo P · Molecules · 2022 · in vitro

In vitro / animal · Verified

The authors optimised extraction of the total flavonoid fraction of B. officinalis, identifying luteolin, apigenin and acacetin as its main monomers, and showed that the fraction protected cultured lens cells against hydrogen-peroxide-induced oxidative damage by modulating antioxidant defences and autophagy. This is a cell-culture result relevant to the herb's cataract indication; it is not evidence of clinical benefit.

doi:10.3390/molecules27248985

The extract of buddleja officinalis maxim. alleviates UVB-induced oxidative damage via the NRF2 pathway in HaCaT cells

Zhu X, Chen Z, Deng B, Yang C, Xiao F · Pharmaceutical Biology · 2025 · in vitro

In vitro / animal · Not yet verified

In UVB-irradiated HaCaT human keratinocytes the extract reduced reactive oxygen species and cell death through NRF2-mediated antioxidant signalling. A keratinocyte model supporting a cosmetic photoprotection claim rather than any traditional indication of the drug.

doi:10.1080/13880209.2025.2540348

Safety

Contraindications

No special contraindications.

Source: Xi S, Gong Y. Essentials of Chinese Materia Medica and Medical Formulas. Academic Press/Elsevier, 2017, pp. 37–43.

Cultural and historical

Kai Bao Ben Cao · Northern Song dynasty, 973 CE

The first materia medica to record Mi Meng Hua. It gives the drug as sweet and cool and assigns it the Liver-channel eye indications, blurred vision, screens and films over the eye, red painful eyes and excessive tearing, that have defined its use ever since.

Ben Cao Gang Mu · Ming dynasty, 1596 CE

Li Shizhen carries the drug forward under the Liver-heat eye category and records the practice of steeping the buds in wine and honey before drying, the processing step still described as mi zhi Mi Meng Hua and used when the intent is to enrich Liver blood rather than simply drain heat.

References

  1. Xie G, Xu Q, Li R, Shi L, Han Y, Zhu Y, Wu G, Qin M. Chemical profiles and quality evaluation of Buddleja officinalis flowers by HPLC-DAD and HPLC-Q-TOF-MS/MS. Journal of Pharmaceutical and Biomedical Analysis. 2019 doi:10.1016/j.jpba.2018.10.030
  2. Guo H, Koike K, Li W, Satou T, Guo D, Nikaido T. Saponins from the Flower Buds of Buddleja officinalis. Journal of Natural Products. 2003 doi:10.1021/np0300131
  3. Xie G, Yang J, Wei X, Xu Q, Qin M. Separation of acteoside and linarin from Buddlejae Flos by high-speed countercurrent chromatography and their anti-inflammatory activities. Journal of Separation Science. 2020 doi:10.1002/jssc.201901062
  4. Huang FB, Liang N, Hussain N, Zhou XD, Ismail M, Xie QL, Yu HH, Jian YQ, Peng CY, Li B, Liu B, Chen SH, Peng QH, Wang W. Anti-inflammatory and antioxidant activities of chemical constituents from the flower buds of Buddleja officinalis. Natural Product Research. 2021 doi:10.1080/14786419.2021.1952577
© Verscienta Health — use subject to the API terms at https://verscienta.com/developers/api; educational reference, not medical advice